Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors

U Galli, C Travelli, A Massarotti… - Journal of medicinal …, 2013 - ACS Publications
Nicotinamide phoshophoribosyltransferase (NAMPT) plays a key role in the replenishment
of the NAD pool in cells. This in turn makes this enzyme an important player in bioenergetics …

Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death

GR Velma, IS Krider, ETM Alves… - Journal of Medicinal …, 2024 - ACS Publications
Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the rate-limiting step in NAD+
biosynthesis via salvage of NAM formed from catabolism of NAD+ by proteins with NADase …

CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells

A Grozio, G Sociali, L Sturla, I Caffa, D Soncini… - Journal of Biological …, 2013 - ASBMB
NAD+ is mainly synthesized in human cells via the" salvage" pathways starting from
nicotinamide, nicotinic acid, or nicotinamide riboside (NR). The inhibition with FK866 of the …

Small dataset solves big problem: An outlier-insensitive binary classifier for inhibitory potency prediction

T Zhou, H Dou, J Tan, Y Song, F Wang… - Knowledge-Based Systems, 2022 - Elsevier
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors show importance in cancer
disease treatment while selecting compounds from a library according to inhibitory potency …

Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives

F Wen, G Gui, X Wang, L Ye, A Qin, C Zhou… - Bioorganic & Medicinal …, 2024 - Elsevier
Nicotinamide phosphoribosyltransferase (NAMPT) is a key rate-limiting enzyme in the
nicotinamide adenine dinucleotide (NAD+) salvage pathway, primarily catalyzing the …

Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors

X Zheng, P Bauer, T Baumeister… - Journal of medicinal …, 2013 - ACS Publications
Nicotinamide phosphoribosyltransferase (Nampt) is a promising anticancer target. Virtual
screening identified a thiourea analogue, compound 5, as a novel highly potent Nampt …

Auto‐Tandem Catalysis with Ruthenium: From o‐Aminobenzamides and Allylic Alcohols to Quinazolinones via Redox Isomerization/Acceptorless Dehydrogenation

W Zhang, C Meng, Y Liu, Y Tang… - Advanced Synthesis & …, 2018 - Wiley Online Library
A strategy for the synthesis of quinazolinones via Ru‐catalyzed redox isomerization/
acceptorless dehydrogenation was proposed and accomplished. In the presence of a …

A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease

JA Timmons, A Anighoro, RJ Brogan, J Stahl… - Elife, 2022 - elifesciences.org
Insulin resistance (IR) contributes to the pathophysiology of diabetes, dementia, viral
infection, and cardiovascular disease. Drug repurposing (DR) may identify treatments for IR; …

Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience

BF Montecucco, M Cea, I Bauer, D Soncini… - Current drug …, 2013 - ingentaconnect.com
Nicotinamide adenine dinucleotide (NAD+) biosynthesis from nicotinamide is used by
mammalian cells to replenish their NAD+ stores and to avoid unwanted nicotinamide …

Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferase

A Oh, YC Ho, M Zak, Y Liu, X Chen, P Yuen… - …, 2014 - Wiley Online Library
Prolonged inhibition of nicotinamide phosphoribosyltransferase (NAMPT) is a strategy for
targeting cancer metabolism. Many NAMPT inhibitors undergo NAMPT‐catalyzed …